Description
Sold as a lyophilized powder which must be reconstituted with bacteriostatic water.
Originally sold as a 20mg product, but were labeled wrong from the factory. Two lab tests confirmed that these are 10mg vials.
📌 What is Pinealon?
Pinealon is a synthetic tripeptide (Glu–Asp–Arg) originally developed in Russia and studied for its neuroprotective, cognitive-enhancing, and anti-aging properties. It is closely related to peptides produced by the pineal gland, which plays a key role in brain regulation, circadian rhythm, and aging.
Pinealon is primarily researched for brain health, memory, and cellular protection, especially in aging and neurodegenerative contexts.
💡 Main Uses of Pinealon (Experimental / Research Use)
| Use | How It Helps |
|---|---|
| 🧠 Cognitive Support | May improve memory, learning, and mental clarity |
| 🛡️ Neuroprotection | Protects neurons from oxidative stress and age-related damage |
| ⏳ Anti-Aging Research | Studied for slowing age-related cognitive decline |
| ⚡ Brain Energy & Metabolism | Supports mitochondrial function in brain cells |
| 🧬 Gene Regulation | Influences gene expression linked to brain repair and longevity |
⚙️ How Pinealon Works
Enhances neurotransmission and synaptic communication
Acts as an antioxidant, reducing oxidative damage in neurons
Modulates gene expression involved in aging and neural repair
Supports mitochondrial efficiency in brain tissue
Unlike stimulants, Pinealon works at a cellular and genetic level, making its effects more subtle but potentially longer-lasting.
📈 Benefits at a Glance
✅ Supports memory and cognition
✅ Protects brain cells from aging and stress
✅ May slow neurodegenerative processes
✅ Enhances brain energy metabolism
✅ Non-stimulant cognitive support
⚠ Note: Pinealon is not FDA-approved and is considered research-grade in most countries. Most data comes from preclinical and Russian clinical research, particularly in aging and neurological health.
“For Research Use Only, Not Approved for Human Consumption”
Reviews
There are no reviews yet.